AO
BIO icon

Advisor OS’s Bio-Rad Laboratories Class A BIO Stock Holding History

Advisor OS’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,020
Closed -$724K – 342
2023
Q3 		$724K Buy
2,020
+115
+6% +$44.4K 0.11% 165
2023
Q2 		$722K Buy
1,905
+120
+7% +$48.8K 0.12% 167
2023
Q1 		$855K Buy
1,785
+16
+0.9% +$7.49K 0.21% 125
2022
Q4 		$744K Buy
1,769
+379
+27% +$153K 0.2% 117
2022
Q3 		$580K Buy
1,390
+59
+4% +$29.4K 0.17% 116
2022
Q2 		$659K Sell
1,331
-6
-0.4% -$3.13K 0.19% 118
2022
Q1 		$753K Sell
1,337
-620
-32% -$374K 0.22% 108
2021
Q4 		$1.48M Sell
1,957
-131
-6% -$98K 0.3% 82
2021
Q3 		$1.56M Sell
2,088
-92
-4% -$68.9K 0.34% 67
2021
Q2 		$1.41M Buy
2,180
+374
+21% +$228K 0.29% 66
2021
Q1 		$1.03M Buy
1,806
+300
+20% +$178K 0.23% 80
2020
Q4 		$878K Buy
1,506
+336
+29% +$191K 0.24% 61
2020
Q3 		$603K Buy
1,170
+696
+147% +$353K 0.25% 47
2020
Q2 		$214K Buy
+474
New +$209K 0.13% 124

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Advisor OS's BIO Position: Q4 2023 in Review

Advisor OS sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2023, closing a stake of 2,020 shares — an estimated $724K sold.

Advisor OS first reported a position in BIO in Q2 2020 and held it in 14 quarters. The position peaked at $1.56M in Q3 2021. 484 funds tracked by Wall St. Rank hold BIO as of Q4 2023.

  • Advisor OS reported no remaining Bio-Rad Laboratories Class A position as of Q4 2023 after selling out during the quarter.
  • Advisor OS sold 2,020 Bio-Rad Laboratories Class A shares in Q4 2023, an estimated $724K.
  • Advisor OS first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 14 quarters.
  • Advisor OS's Bio-Rad Laboratories Class A position peaked at $1.56M in Q3 2021.
  • 484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.

Based on Advisor OS's 13F filing for Q4 2023, filed 8 Feb 2024.